Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

This study has been completed.
Sponsor:
Information provided by:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00971477
First received: September 1, 2009
Last updated: December 9, 2010
Last verified: December 2010

September 1, 2009
December 9, 2010
August 2009
June 2010   (final data collection date for primary outcome measure)
Psoriasis Area Severity Index (PASI) [ Time Frame: Every 6-8 weeks ] [ Designated as safety issue: Yes ]
Psoriasis Area Severity Index (PASI) [ Time Frame: Every 6 weeks ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00971477 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis
Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

  1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity.
  2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.
  3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.
Not Provided
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Psoriasis
  • Other: Online Teledermatology Care
    Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.
    Other Name: Health care service modality
  • Other: Conventional in Office Care
    Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.
    Other Name: Health care service modality
  • Experimental: Teledermatology
    Online Telemedicine Group
    Intervention: Other: Online Teledermatology Care
  • Active Comparator: Usual Care
    Conventional in-office care
    Intervention: Other: Conventional in Office Care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
64
June 2010
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older at time of consent, may be men or women.
  • Requiring treatment of psoriasis for medically-indicated reasons.
  • Capable of giving informed consent.
  • Able to have their skin imaged by themselves or by family members.

Exclusion Criteria:

  • Non-English speaking individuals.
  • Individuals lacking access to a digital camera and computer with internet connection.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00971477
2009172431
No
April W. Armstrong, MD, UC Davis Department of Dermatology
University of California, Davis
Not Provided
Principal Investigator: April W Armstrong, MD UC Davis Department of Dermatology
University of California, Davis
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP